M2Test provides a service to bone doctors and other bone related diseases specialists for more accurate assessment of bone fracture risk to its patients.
In the U.S., approx. 20 million people over age 50 are affected by osteoporosis of the hip, with 46 million (15%) of Americans in the 65 – and – older age group. Although low bone mineral density is generally associated with higher fracture risk, the majority of fractures affect people at moderate risk.
BESTEST™ increases the likelihood of correctly quantifying the actual risk of osteoporosis-related fracture, providing a low cost complement to the tools currently in use and assuring a better management of the patient.